Company intelligence / Profile preview

TheraGenetics

Atlanta, Georgia, United Statesipgroupplc.com ↗

Ownership: Private
Development stage: Other

Overview

Theragenics is a global leader in manufacturing radioactive brachytherapy seeds, such as TheraSeed® and AgX100®, used primarily for prostate and other localized cancers. The company has over 40 years of experience in medical device innovation, with products used worldwide to improve cancer outcomes. It also offers interventional radiology, cardiology devices, vascular surgery products, wound closure solutions, and veterinary medicine devices.

Therapeutic areas: Oncology
Modalities: DeviceRadiopharmaceutical (radioactive brachytherapy seeds)
Industry: Implantable Medical Devices

Partnerships

Partners with physicians, healthcare providers, and medical associations globally

Beyond the preview

Go deeper on TheraGenetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TheraGenetics.

Explore the full profile